StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

GMABBullishAnalyst Target Updateanalyst
Medium materiality6/10

Genmab price target raised to $70 from $50 at H.C. Wainwright

Oct 29, 2026, 9:30 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The substantial target increase supports a cautiously bullish view, though it reflects one analyst's estimate.

AI summary

What happened, with direct paths to the underlying reporting

H.C. Wainwright raised its GMAB target 40% to $70, about 22% above the posted price of $57.29. This is a bullish analyst opinion, not a company announcement.

  • Target raised 40% to $70.
  • New target is about 22% above the posted price.

Key facts

  1. 01

    Target: $70

  2. 02

    Posted price: $57.29

  3. 03

    Analyst firm: H.C. Wainwright

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.